Background. Six months after a stroke, the hemiplegic arm often remains compromised. More innovative approaches to motor rehabilitation are needed. Objective. The authors compared a motor learning-based approach in a virtual environment with more conventional upper extremity therapy in a pilot trial. Methods. This prospective, single-blinded, randomized controlled trial compared reinforced feedback in a virtual environment (RFVE; n = 27) with a control intervention (n = 20) of progressive therapy for the affected upper extremity. Both treatments were provided for 4 weeks, 5 days per week, with 1-hour treatment sessions daily. The primary outcomes were the Fugl-Meyer Upper Extremity (F-M UE) and Functional Independence Measure (FIM) scores. Kinematic outcomes included mean duration (MD), mean linear velocity (MLV), and number of submovements to measure the motor performance. Analyses of the primary outcomes were performed per protocol and by intention to treat. Results. F-M UE scores improved significantly in the RFVE group compared with the conventional therapy group ("intention to treat" = 5.10 points, P = .004; ANCOVA = 4.26 points, P < .01). Several of the kinematic parameters improved in the RFVE group (MD, P < .01; MLV, P < .01). FIM improvements did not differ. Conclusions. Both rehabilitation therapies improved arm motor performance and functional activity, but the RFVE therapy induced more robust results in patients exposed to late rehabilitation treatment.
Introduction
Stroke leads to permanent neurological impairment in up to 600 million people worldwide. 1, 2 In up to 75% of the subjects, motor deficits involve the upper limb. 3 Six months after a stroke, the upper limb is not functional in 30% to 66% of patients. 4 Some degree of potential for improvement, however, may persist in relation to a task-oriented rehabilitation program for up to 2 years after stroke, 5 highlighting the need for a late rehabilitation program. Currently, traditional rehabilitative interventions are mainly focused on the passive facilitation of isolated movements or on the promotion of alternative movements to those used before stroke. 6, 7 Alternatively, new rehabilitative approaches based on the neurophysiological learning mechanisms may be more efficient. 8 The use of virtual reality (VR) technology in neurorehabilitation derives from research in computational neuroscience involving motor learning mechanisms. 9 Recent studies have reported that appropriate feedback about movement patterns (ie, knowledge of performance) and movement parameters (ie, knowledge of results) may help improve motor performance in healthy subjects. [7] [8] [9] [10] [11] Todorov et al 11 reported that subjects trained in a virtual environment with artificially augmented feedback executed a new, complex, multijoint motor task better than those trained with conventional methods. Consequently, the aforementioned methodology has also been employed to stimulate learning in motor-compromised subjects after stroke, showing improvement in both virtual and real tasks.
The aim of this investigation was to determine if a rehabilitation technique that aimed to augment the possibility of motor learning using VR could improve motor outcome scores significantly more than conventional therapy (CT) after stroke. For this purpose, we compared the effects of a VR-based technique (reinforced feedback in a virtual environment [RFVE] ) that supplies kinematic information about arm movement with the effects of CT in treating the upper limb. We chose clinical scales as primary outcomes and kinematic parameters as secondary outcomes.
Materials and Methods Patients
The study was conducted at San Camillo Hospital, where, according to Italian National Health System guidelines, the stroke team can admit a minority of patients (about 10%) several months after a stroke, if they are judged to be likely to benefit from a short period of restorative therapy. These patients were considered eligible to participate in this study.
Patients were assessed for their eligibility by the examining neurologists according to the following inclusion criteria: a single ischemic stroke in the region of the middle cerebral artery (MCA), demonstrated by computerized tomography or magnetic resonance imaging, at least 6 months before the entry; conventional physical therapy treatment received in the early period after stroke; and mild to intermediate motor impairment of the arm assessed by a FuglMeyer Upper Extremity (F-M UE) score between 20 and 60 at baseline.
14 Clinical history or evidence of memory impairment, neglect, apraxia, or aphasia interfering with verbal comprehension were exclusion criteria.
Interventions
Throughout the duration of the trial, 2 groups of 7 physical therapists were involved with the experimental RFVE treatment and conventional physical therapy.
For RFVE, the subject was asked to perform different kinds of motor tasks while the movement of the entire biomechanical arm system's end section (end-effector) was simultaneously represented in a virtual scenario by means of motion-tracking equipment. The equipment included a computer workstation connected to a 3D motion-tracking system (Polhemus 3Space FasTrak, Colchester, VT) and a high-resolution LCD projector displaying the virtual scenarios on a large wall screen. The electromagnetic 3D motion-tracking sensor was positioned on a manipulatable object (eg, rubber ball, polystyrene cube) held by the subject or was alternatively attached to a glove worn by the patient in cases of severe grasping deficits. The physical therapist could create numerous virtual motor tasks for the arm through the use of flexible software developed at the Massachusetts Institute of Technology (Cambridge, MA), which elaborated the motion data coming from the endeffector receiver. The software permitted the alignment of the virtual scene with the patients' positions, applying a rigid body transformation to the entire scenario, and the synchronization of the teacher animation with patient movement. 15 The RFVE therapist selected the characteristics and complexity of the motor tasks to suit each patient's arm deficit. In the virtual scenario, the therapist determined the starting position and the target of each task, such as target orientation or the addition of other virtual objects, to increase the complexity of the task. A simple reaching movement could accomplish some tasks, whereas others required more complicated movements.
During the RFVE therapy, patients were asked to perform motor tasks according to constraints specified beforehand by the therapist. Subjects were given information about their arm movements during the performance of motor skills (ie, knowledge of performance [KP] ) by the movement of the virtual representation of the end-effector. The therapist's movement and trajectory was displayed in the background of the virtual scene to facilitate the subject's perception and adjustment to motion errors (learning by imitation). 16 Moreover, knowledge of results (KR) regarding motor task correctness was supplied to patients in the form of standardized scores and by displaying arm trajectory morphology on the screen. Initially, the above-mentioned KP and KR were provided at a frequency of more than 90%, but this was gradually decreased as performance improved.
In all the trials, the subject, seated in front of the wall screen where the scene was represented, had to move from a starting position at knee level to a target positioned 75 cm in front of the ipsilateral shoulder and approximately 60 cm above the starting position in the same sagittal plane (Figure 1 ). The different orientations of the target (eg, horizontal, vertical, and diagonal on the subject's frontal plane) determined the complexity of the movement in terms of involving the activation of different muscles. The CT program was based on Bobath principles. The subjects were asked to perform specific exercises with the upper limb with progressive complexity. First, the patients were asked to control isolated motions without postural control; subsequently, postural control was included; and finally, complex motion with postural control was practiced. For example, patients were asked to touch different targets arranged on a horizontal plane in front of them to manipulate different objects, to follow trajectories displayed on a plane, or to recognize different arm positions.
All the RFVE treatment sessions were automatically recorded by dedicated software, whereas CT sessions were reported in detail each week by the physical therapist.
The treatment protocol consisted of 1 hour of RFVE or CT therapy daily, 5 days per week, for 4 weeks.
Outcome Measures
Before and after the treatment in both groups, the degree of motor impairment and independence in daily living activities were evaluated with the F-M UE score and the Functional Independence Measure (FIM) scale. 17 At the same time, we determined the mean duration (MD, in seconds), mean linear velocity (MLV, in cm/s), and number of submovements (SM) in 36 motor trials organized into 4 different reaching tasks.
Submovements indicate movement smoothness. To calculate the submovements, we sampled the sensor position (pos i ) with a frequency of 120 Hz and then derived the mean velocity (v k ) every 0.1 seconds as follows:
and we considered 1 submovement if
Randomization and Allocation Concealment
The local ethics committee approved the protocol, and written consent was obtained from all participants. The subjects and physical therapists were allocated to the RFVE or CT treatment group by the therapist coordinator, according to a simple randomization technique using sequentially numbered, opaque sealed envelopes. The envelopes containing the paper sheet with the type of treatment and a sheet of carbon paper were obscured with aluminum foil, shuffled, then numbered sequentially, and placed in a plastic container, in numerical order, ready to use for the allocation.
The clinical assessments before and after treatment were carried out by a neurologist who was not involved in patient selection and was blinded to the treatment. The kinematic parameters were automatically recorded by the VR equipment.
Statistical Analysis
The study sample size calculation was based on previous results 18 in which the minimal clinically important difference was defined as 10% of the total range of the F-M UE score, that is, 6.6 points. To have a 0.8 power and a Cohen's d effect size equal to 0.6 with F-M UE as primary outcome (normality assumption), the sample size needed was estimated at 23 in each group.
The analysis focused on clinical (F-M UE and FIM) and kinematic (MD, MLV, and SM) variables. Data were expressed as mean ± standard deviation (SD). Depending on the assumption of normality (Shapiro-Wilk's test) and on the results of homogeneity of variance (F test), we used parametric (Student's t test) or nonparametric tests (Wilcoxon test, MannWhitney test) to study differences between experimental and control groups and between pretreatment (PRE) and posttreatment (POST) measurements. Moreover, 95% parametric or nonparametric confidence intervals were computed for clinical and kinematic variables. In addition, analysis of covariance (ANCOVA) was used to study if posttreatment clinical measurements covaried with the pretest measurement in experimental and control groups. Analyses of the primary outcomes were performed by both "per protocol" and "intention to treat."
In case data were missing at follow-up, we envisioned 3 different scenarios: the likely, the worst, and the best. In the likely scenario, the missing data were imputed as the mean outcome value of the referred group. In the worst scenario, the missing data were imputed as the mean outcome value minus SD for the RFVE group and the mean outcome value plus SD for the CT group. In the best scenario, the missing data were imputed inversely to the worst scenario.
All the statistical analyses were executed using the freeware R. 19 A significance level of P < .05 was used, adjusted for multiple comparisons by using the Bonferroni correction. 
Results
Among 292 patients with a single ischemic stroke in the territory of MCA at least 6 months before the evaluation who were admitted to the stroke unit from January 2001 to December 2007, 242 were excluded: 223 subjects did not meet the inclusion criteria regarding cognition levels and the FM UE range, whereas 19 subjects refused to participate in the study. We enrolled 50 subjects for the study: 27 were randomly assigned to the RFVE treatment group and 23 to the CT group. In the CT group, 3 patients dropped out of the study: 1 patient because of the onset of Paget-Schroetter disease in the affected arm and 2 patients because of arm fractures caused by accidental falls.
In the RFVE (median = 4 patients/care provider) and CT (median = 3 patients/care provider) groups, 27 and 20 subjects were treated, respectively. Both groups underwent therapy in daily 1-hour treatment sessions, 5 days per week, for 4 weeks (mean session number and SD 21.3 ± 4.5 and 20.9 ± 5.1, respectively, for RFVE and CT groups; Figure 2 ).
During the study, none of the patients used any medications known to interfere with the central nervous system (CNS; eg, antidepressant drugs). None of the patients who underwent RFVE therapy complained of any discomfort, such as cybersickness, altered eye-motor coordination, or postural disequilibrium, due to interaction with the virtual world. Table 1 summarizes the baseline demographic characteristics of the RFVE and CT groups. In Table 2 , we show the functional and kinematic results of the per protocol analysis. The per protocol analysis did not show statistically significant differences between groups for the F-M UE scale after the treatment. Pretreatment and posttreatment FIM measurements were lower in the CT group when compared with the RFVE group (P < .000, P < .001, respectively), allowing a meaningful comparison only by ANCOVA analysis.
In the RFVE and CT groups, we found a change within the groups for the F-M UE score (P < .00, P < .02, respectively) and the FIM score (P < .00, P < .04, respectively).
ANCOVA analysis (F = 72.15, P < .001) revealed that F-M UE-POST measurements were systematically lower in control patients compared with RFVE subjects (-4.26 ± 1.45, P < .01). Moreover, the slope of the relationship between pretreatment and posttreatment F-M UE values is the same in the 2 groups (0.81 ± 0.07, P < .000). The estimated model is shown in Figure 3A . Similarly, ANCOVA analysis (F = 66.17, P < .001) in Figure 3B shows that FIM-POST measurements were systematically lower in control patients when compared with RFVE subjects (-4.58 ± 1.74, P < .02). Moreover, the slope of the relationship between pretreatment and posttreatment F-M UE values is the same in the 2 groups (0.61 ± 0.06, P < .000).
Two kinematic variables (MD and MLV) changed significantly after treatment for the experimental subjects (P < .01, P < .01, respectively) in contrast to SM values (P = .13) and to all kinematic measurements in control subjects (P = .66, P = .99, and P = .32, respectively). In the comparison between groups, we found no significant difference for the kinematic variables. Table 3 provides the results of the intention-to-treat analysis. In the comparison between groups, we found a statistically significant difference in the best scenario (P = .004) that disappeared in the likely and worst scenarios (P = .080, P = .64, respectively) for the F-M UE score. We did not find a statistically significant difference in any scenario (P =1.00, P = 1.00, P = .36, respectively) for the FIM scale. In the comparison within groups, the results held steady for the RFVE group, whereas in the CT group we observed a statistically significant difference in the likely and worst scenarios (P = .008, P = .002, respectively), but not in the best scenario (P = .64).
Discussion
The aim of this study was to compare 2 different rehabilitation techniques to improve motor control of the upper extremity and to improve overall functional independence. Currently, no randomized controlled study has shown to what extent any recovery is due to specific rehabilitation strategies in late stabilized poststroke patients with a mild to moderate motor impairment of the upper extremity. 6, 13, 20 In patients with mild to intermediate motor impairment due to a single stroke in the region of the MCA of at least 6 months duration, the RFVE treatment induced better motor performance compared with the conventional one. The intention-to-treat analysis showed a statistically significant difference between groups in the best scenario. For the comparison within groups, the statistical difference was maintained in all the RFVE group simulations and only in the worst scenario for the CT group. In addition, the ANCOVA analysis showed that improvement in terms of score was systematically better in the RFVE group, with 4.26 ± 1.45 points for the F-M UE score (P < .01). Finally, no treatment effect emerged for the per protocol analysis. For kinematics, the MD, MLV, and SM improved significantly in the RFVE group alone. These results confirm that late therapy may improve motor performance, as suggested in previous studies using different rehabilitation techniques.
5,21
These results were consistent with the RFVE rationale based on the amplification of kinematic feedback to promote motor recovery, thus exploiting motor learning mechanisms. These motor learning mechanisms are related to computational theories of motor control, which are concerned with 2 main issues. The first is the relationship between humans and the environment, with the consequent sensory signals originating from mismatch due to the mode of interaction; the second involves the invariant rules of the CNS that govern motor behavior performed in a context limited by the physics of the environment, the musculoskeletal system, and sensory receptors. 22, 23 In this loop, which involves the body and the environment, every stage of the interaction is represented in the CNS as an internal model, working like a motor primitive and allowing learning by adaptation due to repeated exposure to sensory environmental signals. 24 Thus, VR technologies may make it possible to create enriched computer-controlled environments to assess computational models of motor learning 25 and to optimize the fine-tuning of motor plans disrupted by brain lesions.
On the other hand, recent neurophysiological studies on primates have demonstrated that cortical cells in motor and premotor areas respond selectively to kinematic variations during motor adaptation tasks. These cells, clearly identified in the monkey SMA, are involved in the kinematics-todynamics transformation process and, hence, in new motor task learning. 26 An important aspect of our study was the consistency of the feedback provided to patients about arm kinematics, as Cirstea et al 27 demonstrated for skill relearning in poststroke patients. In our VR setting, patients were given information about their arm movements during the performance of motor skills (KP), consisting of a representation of their end-effector and "virtual teacher" movement, which showed the actual kinematics of the hand path to practice "learning by imitation." 18 Furthermore, in our setup, this virtual representation of the correct movement, coupled with instructions imparted by the therapist during experimental training, reinforced the so-called supervised learning. The object trajectories that were displayed on screen allowed patients to evaluate the accuracy of their movement (KR), thereby promoting the identification of successful motor strategies through the trialand-error paradigm. A second kind of KR provided to patients was a reward delivered when the task performance score surpassed a preestablished threshold. These 2 phenomena contributed to generate the basis for a "reinforcement learning" mechanism. Kinematic information has been demonstrated to be beneficial in human motor learning, 10, 11, 28 as well as in poststroke patients. 29, 30 In our opinion, the synergistic activity of supervised reinforcement and learning by imitation facilitates faster development of the kinematic internal models essential for motor learning.
Recent studies in the context of neurological rehabilitation after stroke have shown that patients may benefit from exercise programs in which functional tasks are directly and intensively trained. The RFVE therapy was focused on a task-oriented strategy, using a virtual environment representing activities commonly practiced in social contexts such as the patient's own home.
We measured how much the RFVE activity could influence a patient's autonomy in activities of daily life through a clinically validated tool, the FIM. No difference emerged between the 2 groups, although the ANCOVA analysis showed that improvement in terms of score was systematically better in the RFVE group by 4.58 ± 1.74 points (P < .02). Within both groups the FIM improvement was statistically significant, except for the best scenario in the CT group. The modification of the FIM score underlined the validity of both approaches for functional gains, although subjects could improve on this scale without necessarily making greater use of the affected UE.
In this trial, the control group was affected by a significant attrition bias that underpowered the results at the followup. In the intention-to-treat analysis, the RFVE treatment emerged as being better following an imputation technique and confirmed by the ANCOVA. Consequently, a future trial should enroll a larger patient sample and experiment with higher intensities of therapy. Another relevant issue to pursue is the motivation of patients to continue in rehabilitation programs. The opportunity to supply patients with a measurement of motor performance appeared to generate a self-competitive stimulus to progressively improve the correctness of arm trajectories session by session.
In conclusion, this pilot study offers a preliminary demonstration that RFVE therapy can induce better upper extremity motor outcome in patients beyond 6 months after onset of stroke and supports the potential value of each intervention to enhance functional activities.
